Lagotto Romagnolo puppies may suffer from a serious genetic disorder called lysosomal storage disease (LSD), also known as Lagotto storage disease. This inherited condition disrupts the dog’s metabolic processes due to a lack of enzymes necessary to break down and clear cellular waste.
Without these critical enzymes, waste substances accumulate abnormally within cells, particularly in the nervous system. This buildup causes cells to enlarge or die, resulting in progressive neurological damage.
LSD is a fatal disease with no available cure. While lysosomal storage diseases affect humans and other animals, the form observed in Lagotto Romagnolos is breed-specific and is relatively well-studied.
Importantly, LSD is not contagious; a dog must inherit two copies of the defective gene—one from each parent—to develop the illness. Dogs carrying only one copy are healthy carriers who do not show symptoms but can pass the gene to their offspring.
In the United States, responsible breeders utilize genetic testing schemes supported by organizations such as the Lagotto Romagnolo Foundation. These tests help identify carriers and affected dogs, enabling informed breeding to reduce the disease's prevalence.
This condition arises from a mutation in the ATG4D gene, which regulates an enzyme critical for lysosomal recycling—the cellular process of breaking down and eliminating unwanted material. When this system malfunctions, harmful waste accumulates, primarily damaging nervous system cells.
Symptoms usually emerge anywhere from 4 months to 4 years of age and vary in severity. Early signs often include neurological symptoms such as loss of balance (ataxia), repeated involuntary eye movements (nystagmus), clumsiness, unusual restlessness, mood changes including depression, and odd aggression. Unfortunately, symptoms generally worsen over time and severely impact the dog’s quality of life.
Diagnosis relies heavily on genetic testing since clinical signs overlap with other neurological problems and can be misleading.
Any purebred Lagotto Romagnolo in the US can inherit the mutated LSD genes. The disease manifests only when the dog receives two copies of the mutation, making it an autosomal recessive disorder.
Mixed-breed dogs carrying a single mutated gene often remain healthy thanks to genetic diversity, although they may still pass the gene to offspring.
LSD in Lagotto Romagnolos is inherited as an autosomal recessive trait, classifying dogs into three genetic categories:
Breeding outcomes vary based on parents' genetic status:
Genetic testing is essential for responsible breeding to prevent LSD in the US. Breeders and owners are encouraged to have their dogs tested before breeding to ensure no affected puppies are produced.
Testing is done by collecting a DNA sample—typically via cheek swab or blood draw—by a veterinarian and sending it to a specialized lab affiliated with the Lagotto Romagnolo Foundation or other accredited organizations. Results determine whether the dog is clear, a carrier, or affected.
With this information, breeders in the USA can avoid mating two carriers and reduce LSD incidence while maintaining genetic diversity in the breed.
The existence of precise genetic tests for LSD empowers American breeders and owners to make informed choices that enhance the health of Lagotto Romagnolos. Adhering to these testing protocols plays a pivotal role in decreasing this devastating disease's frequency.
If you plan to bring home a Lagotto Romagnolo puppy, always seek reputable US breeders who perform thorough genetic testing for LSD and other inherited conditions. This ensures you receive a healthy puppy and helps preserve the breed’s long-term health.
Veterinarians in the US recommend regular checkups to spot neurological or behavioral changes early, genetic counseling for breeders to understand the significance of carrier status, and educating owners about symptom recognition and management, even though no cure currently exists. Prevention through responsible breeding is the best strategy.